Abstract:Experimental models of the central nervous system (CNS) are imperative for developmental and pathophysiological studies of neurological diseases. Among these models, three-dimensional (3D) induced pluripotent stem cell (iPSC)-derived brain organoid models have been successful in mitigating some of the drawbacks of 2D models; however, they are plagued by high organoid-to-organoid variability, making it difficult to compare specific gene regulatory pathways across 3D organoids with those of the native brain. Single-cell RNA sequencing (scRNA-seq) transcriptome datasets have recently emerged as powerful tools to perform integrative analyses and compare variability across organoids. However, transcriptome studies focusing on late-stage neural functionality development have been underexplored. Here, we combine and analyze 8 brain organoid transcriptome databases to study the correlation between differentiation protocols and their resulting cellular functionality across various 3D organoid and exogenous brain models. We utilize dimensionality reduction methods including principal component analysis (PCA) and uniform manifold approximation projection (UMAP) to identify and visualize cellular diversity among 3D models and subsequently use gene set enrichment analysis (GSEA) and developmental trajectory inference to quantify neuronal behaviors such as axon guidance, synapse transmission and action potential. We showed high similarity in cellular composition, cellular differentiation pathways and expression of functional genes in human brain organoids during induction and differentiation phases, i.e., up to 3 months in culture. However, during the maturation phase, i.e., 6-month timepoint, we observed significant developmental deficits and depletion of neuronal and astrocytes functional genes as indicated by our GSEA results. Our results caution against use of organoids to model pathophysiology and drug response at this advanced time point and provide insights to tune in vitro iPSC differentiation protocols to achieve desired neuronal functionality and improve current protocols.

Single-cell transcriptomics captures features of human midbrain development and dopamine neuron diversity in brain organoids

Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain

Multiplexing cortical brain organoids for the longitudinal dissection of developmental traits at single cell resolution

Generation of human midbrain organoids from induced pluripotent stem cells

Individual brain organoids reproducibly form cell diversity of the human cerebral cortex

Interspecies Organoids Reveal Human-Specific Molecular Features of Dopaminergic Neuron Development and Vulnerability

In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain-striatum-cortex assembloids

Brain organoids: Human 3D models to investigate neuronal circuits assembly, function and dysfunction

In vivo development and single‐cell transcriptome profiling of human brain organoids

Inferring and perturbing cell fate regulomes in human brain organoids

Modelling human brain development and disease with organoids

Dopamine Neuron Diversity: Recent Advances and Current Challenges in Human Stem Cell Models and Single Cell Sequencing

Human 3D brain organoids: steering the demolecularization of brain and neurological diseases

An in vivo and in vitro spatiotemporal atlas of human midbrain development

Transcriptomic Mapping of Neural Diversity, Differentiation and Functional Trajectory in iPSC-Derived 3D Brain Organoid Models

Inferring and perturbing cell fate regulomes in human cerebral organoids

Single-cell transcriptomics identifies perturbed molecular pathways in midbrain organoids using α-synuclein triplication Parkinson's disease patient-derived iPSCs

Deriving early single-rosette brain organoids from human pluripotent stem cells

Human cerebral organoids recapitulate gene expression programs of fetal neocortex development

Maturation and circuit integration of transplanted human cortical organoids

Brain organoids: A new tool for modelling of neurodevelopmental disorders